This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Worldview of Psychiatry

Worldview of Psychiatry

Herbert Y. Meltzer, MD

Published: January 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Treatment of ideopathic psychotic disorders including schizophrenia and mania was revolutionized by the serendipitous discovery of the phenothiazines (initially, chlorpromazine) and subsequent development of the thioxanthenes (e.g., thiothixene), butyrophenes (e.g., haloperidol), and their congeners in the 1950s. Virtually all of these drugs block dopamine D2 receptors in direct correlation with their clinical potency as antipsychotic agents. However, these classic or “typical” neuroleptic agents regularly induce characteristic neurologic and endocrinologic side effects including dystonia, akathisia, bradykinesia, acute or late dyskinesias, and hyperprolactinemia.

Volume: 65

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...